# Eton Pharmaceuticals, Inc.: Form 8-K, filed May 1, 2026

- Company: [Eton Pharmaceuticals, Inc.](/companies/eton.md) (CIK 1710340)
- Form: 8-K
- Filed: 2026-05-01
- Accepted by EDGAR: May 1, 2026, 07:05 ET
- Period: 2026-05-01
- Accession: 0001437749-26-014315
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1710340/000143774926014315/eton20260429_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1710340/000143774926014315/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1710340/000143774926014315/eton20260429_8k.htm

Filed May 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-014315. Last ingested by Listed: Nov 6, 2026, 16:36 ET. No prices; not investment advice.